Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 400mg;   - modified release tablet - 400 mg - active: carbamazepine 400mg   excipient: carmellose sodium colloidal silicon dioxide ethylcellulose hypromellose yellow, red, white suspension iron oxide red iron oxide yellow magnesium stearate methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil purified talc   purified water titanium dioxide - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

devatis limited - imatinib mesilate 119.5mg equivalent to imatinib 100 mg;  ; imatinib mesilate 119.5mg equivalent to imatinib 100 mg - film coated tablet - 100 mg - active: imatinib mesilate 119.5mg equivalent to imatinib 100 mg   excipient: colloidal silicon dioxide crospovidone hypromellose opadry ii orange 85f230022 magnesium stearate microcrystalline cellulose active: imatinib mesilate 119.5mg equivalent to imatinib 100 mg excipient: colloidal silicon dioxide crospovidone hypromellose opadry ii orange 85f230022 magnesium stearate microcrystalline cellulose - treatment of adult and paediatric patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (ph+cml). treatment of adult and paediatric patients with ph+cml in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

devatis limited - imatinib mesilate 478mg equivalent to imatinib 400 mg;  ; imatinib mesilate 478mg equivalent to imatinib 400 mg - film coated tablet - 400 mg - active: imatinib mesilate 478mg equivalent to imatinib 400 mg   excipient: colloidal silicon dioxide crospovidone hypromellose opadry ii orange 85f230022 magnesium stearate microcrystalline cellulose active: imatinib mesilate 478mg equivalent to imatinib 400 mg excipient: colloidal silicon dioxide crospovidone hypromellose opadry ii orange 85f230022 magnesium stearate microcrystalline cellulose - treatment of adult and paediatric patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (ph+cml). treatment of adult and paediatric patients with ph+cml in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - maprotiline hydrochloride 25mg;   - film coated tablet - 25 mg - active: maprotiline hydrochloride 25mg   excipient: calcium phosphate colloidal silicon dioxide hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch polysorbate 80 purified talc   stearic acid titanium dioxide - depression endogenous and late-onset (involutional) depression. psychogenic, reactive, and neurotic depression, exhaustion depression. somatogenic depression masked depression menopausal depression other depressive mood disorders characterised by anxiety, dysphoria, or irritability; apathetic states(especially in the elderly); psychosomatic and somatic symptoms with underlying depression and/or anxiety the diagnostic and statistical manual of mental disorders (dsm-iv-tr) and the international statistical classification of diseases and related health problems (icd-10) are standard classifications of mental disorders used by mental health professionals and describe the above mentioned disorders as follows: treatment of depressive episodes, recurrent depressive disorder or major depression.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - maprotiline hydrochloride 75mg;   - film coated tablet - 75 mg - active: maprotiline hydrochloride 75mg   excipient: calcium phosphate colloidal silicon dioxide hypromellose iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch polysorbate 80 purified talc   stearic acid titanium dioxide - depression endogenous and late-onset (involutional) depression. psychogenic, reactive, and neurotic depression, exhaustion depression. somatogenic depression masked depression menopausal depression other depressive mood disorders characterised by anxiety, dysphoria, or irritability; apathetic states(especially in the elderly); psychosomatic and somatic symptoms with underlying depression and/or anxiety the diagnostic and statistical manual of mental disorders (dsm-iv-tr) and the international statistical classification of diseases and related health problems (icd-10) are standard classifications of mental disorders used by mental health professionals and describe the above mentioned disorders as follows: treatment of depressive episodes, recurrent depressive disorder or major depression.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxcarbazepine 150mg;  ;  ;   - film coated tablet - 150 mg - active: oxcarbazepine 150mg       excipient: colloidal silicon dioxide crospovidone hypromellose   iron oxide black iron oxide red iron oxide yellow macrogol 4000 magnesium stearate powdered cellulose purified talc titanium dioxide - trileptal is indicated in adults and children aged 1 month and above for the treatment of · partial seizures (which include the seizure subtypes of simple, complex and partial seizures evolving to secondarily generalised seizures) and · generalised tonic-clonic seizures. trileptal is indicated as a first-line antiepileptic drug for use as monotherapy or adjunctive therapy. trileptal can replace other antiepileptic drugs when current therapy provides insufficient seizure control.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxcarbazepine 300mg;  ;   - film coated tablet - 300 mg - active: oxcarbazepine 300mg     excipient: colloidal silicon dioxide crospovidone hypromellose   iron oxide yellow macrogol 8000 magnesium stearate powdered cellulose purified talc titanium dioxide - trileptal is indicated in adults and children aged 1 month and above for the treatment of · partial seizures (which include the seizure subtypes of simple, complex and partial seizures evolving to secondarily generalised seizures) and · generalised tonic-clonic seizures. trileptal is indicated as a first-line antiepileptic drug for use as monotherapy or adjunctive therapy. trileptal can replace other antiepileptic drugs when current therapy provides insufficient seizure control.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - oxcarbazepine 600mg;  ;  ;   - film coated tablet - 600 mg - active: oxcarbazepine 600mg       excipient: colloidal silicon dioxide crospovidone hypromellose   iron oxide black iron oxide red macrogol 4000 magnesium stearate powdered cellulose purified talc titanium dioxide - trileptal is indicated in adults and children aged 1 month and above for the treatment of · partial seizures (which include the seizure subtypes of simple, complex and partial seizures evolving to secondarily generalised seizures) and · generalised tonic-clonic seizures. trileptal is indicated as a first-line antiepileptic drug for use as monotherapy or adjunctive therapy. trileptal can replace other antiepileptic drugs when current therapy provides insufficient seizure control.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25mg;  ;   - enteric coated tablet - 25 mg - active: diclofenac sodium 25mg     excipient: ammonia solution colloidal silicon dioxide hypromellose   silicone antifoam emulsion (enteric-coat)   pigment suspension white   pigment suspension white (colour-coat) lactose monohydrate macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil   povidone purified talc     purified water     sodium starch glycolate - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 50mg;  ;   - enteric coated tablet - 50 mg - active: diclofenac sodium 50mg     excipient: colloidal silicon dioxide hypromellose   silicon antifoam emulsion se2, enteric coat iron oxide red   iron oxide yellow   lactose monohydrate macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil   povidone purified talc   sodium starch glycolate titanium dioxide   - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.